These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

369 related items for PubMed ID: 21200170

  • 1. The asthmatic athlete: inhaled Beta-2 agonists, sport performance, and doping.
    McKenzie DC, Fitch KD.
    Clin J Sport Med; 2011 Jan; 21(1):46-50. PubMed ID: 21200170
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Ergogenic effects of inhaled beta2-agonists in non-asthmatic athletes.
    Wolfarth B, Wuestenfeld JC, Kindermann W.
    Endocrinol Metab Clin North Am; 2010 Mar; 39(1):75-87, ix. PubMed ID: 20122451
    [Abstract] [Full Text] [Related]

  • 4. Pharmaceutical treatment of asthma symptoms in elite athletes - doping or therapy?
    Backer V, Lund T, Pedersen L.
    Scand J Med Sci Sports; 2007 Dec; 17(6):615-22. PubMed ID: 18093034
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [The use of anti-asthmatic medication among Danish elite athletes].
    Lund TK, Pedersen L, Backer V.
    Ugeskr Laeger; 2007 Dec 10; 169(50):4355-9. PubMed ID: 18211794
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Are the prevalence and treatment of asthma similar in elite athletes and the aged-matched non-athlete population?
    Locke S, Marks G.
    Scand J Med Sci Sports; 2007 Dec 10; 17(6):623-7. PubMed ID: 17316378
    [Abstract] [Full Text] [Related]

  • 14. Interview: partnering with the industry: the Olympic laboratory model.
    Cowan DA, Barker CP.
    Bioanalysis; 2012 Jul 10; 4(13):1545-8. PubMed ID: 22831471
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Medication, athletes and doping regulations].
    Hartgens F.
    Ned Tijdschr Geneeskd; 2008 Aug 16; 152(33):1844-8. PubMed ID: 18783164
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.